Opin vísindi

Fletta eftir höfundi "Gizurarson, Sveinbjorn"

Fletta eftir höfundi "Gizurarson, Sveinbjorn"

Röðun: Raða: Niðurstöður:

  • Patlolla, Venu Gopal Reddy; Peter Holbrook, William; Gizurarson, Sveinbjorn; Kristmundsdóttir, Thórdís (MDPI AG, 2019-12-09)
    The aim of this study was to develop a stable aqueous formulation containing a combination of doxycycline and monocaprin in clinically relevant concentrations. Increase in expression of Matrix metalloproteinases (MMPs) and microbial role in oral ...
  • Erdő, Franciska; Bors, Luca Anna; Farkas, Dániel; Bajza, Ágnes; Gizurarson, Sveinbjorn (Elsevier BV, 2018-10)
    The acute or chronic drug treatments for different neurodegenerative and psychiatric disorders are challengingfrom several aspects. The low bioavailability and limited brain exposure of oral drugs, the rapid metabolism,elimination, the unwanted side ...
  • Schijns, Virgil; Fernández‐Tejada, Alberto; Barjaktarović, Žarko; Bouzalas, Ilias; Brimnes, Jens; Chernysh, Sergey; Gizurarson, Sveinbjorn; Gursel, Ihsan; Jakopin, Žiga; Lawrenz, Maria; Nativi, Cristina; Paul, Stephane; Pedersen, Gabriel Kristian; Rosano, Camillo; Ruiz‐de‐Angulo, Ane; Slütter, Bram; Thakur, Aneesh; Christensen, Dennis; Lavelle, Ed C. (Wiley, 2020-06-28)
    Therapeutic vaccination offers great promise as an intervention for a diversity of infectious and non-infectious conditions. Given that most chronic health conditions are thought to have an immune component, vaccination can at least in principle be ...
  • Volmer, Daisy; Sokirskaja, Aleksandra; Laaksonen, Raisa; Vainio, Kirsti; Sandler, Niklas; Halvorsen, Kjell; Kjome, Reidun; Gizurarson, Sveinbjorn; Muceniece, Ruta; Maurina, Baiba; Dauksiene, Jurgita; Ruuben, Lilian; Björnsdottir, Ingunn; Ratassepp, Tagne; Heinämäki, Jyrki (MDPI AG, 2016-10-13)
    With increased development of medical technology (MT), new challenges emerge related to education and training of pharmacists and other healthcare specialists. Currently, only a few universities in the EU promote MT education and research. Objectives: ...
  • Drobnjak, Tijana; Meiri, Hamutal; Mandalá, Maurizio; Huppertz, Berthold; Gizurarson, Sveinbjorn (Dove Medical Press Ltd., 2018-07)
    Introduction: Human placental protein 13 (PP13) is a galectin predominantly expressed by the placenta. Low serum concentrations of PP13 in early pregnancy indicate a higher risk of developing preeclampsia. Methods: The pharmacokinetic disposition ...
  • Drobnjak, Tijana; Jónsdóttir, Anna Margrét; Helgadottir, Helga; Runólfsdóttir, Margrét Soffía; Meiri, Hamutal; Sammar, Marei; Osol, George J.; Mandalà, Maurizio; Huppertz, Berthold; Gizurarson, Sveinbjorn (Informa UK Limited, 2019-03-27)
    Introduction: Reduced concentrations of placental protein 13 (PP13) during the first trimester of human pregnancy are associated with elevated risk for the subsequent development of preeclampsia, which is one of the deadliest obstetrical complications ...
  • Helgadottir, Helga; Ólafsson, Ísleifur Hákon; Andersen, Karl Konráð; Gizurarson, Sveinbjorn (Informa UK Limited, 2019-06-04)
    Introduction: Conventional venous blood collection requires a puncture with a needle through the endothelium of a vessel. The endothelial injury causes activation of circulating platelets and the release of thromboxane A2. The aim of the study was to ...